Insiders · Profile

Mitchell Stephen Ray

Director at Vanda Pharmaceuticals. Filing since 15 Jun 2021. CIK 0001802653

Company
Date
Role
Action
Shares
Amount
Of holding
13 Jun 2025
Director
Sold at will
7,000
$32.13K
6.7%
14 Nov 2024
Director
Sold at will
5,000
$25.86K
10.0%
10 Aug 2023
Director
Sold at will
6,500
$39.35K
18.1%
13 Jun 2022
Director
Sold, plan not stated
2,700
$25.59K
29.3%
9 Sep 2021
Director
Sold, plan not stated
19,109
$319.98K
67.5%
15 Jun 2021
Director
Sold, plan not stated
5,000
$97.12K
35.2%
6 decisions on file.